Axon Enterprise
AXON
#540
Rank
A$65.68 B
Marketcap
A$832.45
Share price
0.39%
Change (1 day)
-17.09%
Change (1 year)

Axon Enterprise (AXON) - Cash on Hand

Cash on Hand as of September 2025 : A$3.67 Billion

According to Axon Enterprise 's latest financial reports the company has A$3.67 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Axon Enterprise - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$1.58 B-18.19%
2023-12-31A$1.93 B35.32%
2022-12-31A$1.43 B134.39%
2021-12-31A$0.61 B-16.39%
2020-12-31A$0.73 B45.87%
2019-12-31A$0.50 B1%
2018-12-31A$0.49 B372.48%
2017-12-31A$0.10 B-15.03%
2016-12-31A$0.12 B-18.01%
2015-12-31A$0.15 B51.99%
2014-12-31A$99.14 M72.15%
2013-12-31A$57.59 M58.3%
2012-12-31A$36.38 M41.26%
2011-12-31A$25.75 M-38.71%
2010-12-31A$42.02 M-17.05%
2009-12-31A$50.65 M-27.62%
2008-12-31A$69.99 M19.28%
2007-12-31A$58.67 M107.14%
2006-12-31A$28.32 M26.76%
2005-12-31A$22.34 M-45.89%
2004-12-31A$41.29 M93.33%
2003-12-31A$21.36 M236.47%
2002-12-31A$6.34 M-42.51%
2001-12-31A$11.04 M2891.46%
2000-12-31A$0.36 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
XBiotech
XBIT
A$0.22 B-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$44.57 M-98.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.48 B-59.57%๐Ÿ‡บ๐Ÿ‡ธ USA